Prevent, alleviate, or heal disease—naturally.
Consult with our health coaches who will learn about your symptoms, habits, and goals.
Take personalized home health tests to discover potential root causes of any symptoms or conditions you may have.
Review your results in just days with our functional medicine doctors, nurses, and dietitians who will help you achieve optimal health.
Ligneous conjunctivitis is a rare medical condition characterized by the formation of woody-like pseudomembranes primarily on the conjunctiva, the membrane lining the eyelid. This chronic condition can extend to affect other mucous membranes in the body. It's part of a group of disorders known as plasminogen deficiency conditions. Its prevalence is not well-defined due to its rarity; however, it disproportionately affects young children and can persist into adulthood if not treated promptly.
Ligneous conjunctivitis primarily results from a severe deficiency in plasminogen, a crucial enzyme in the body's fibrinolytic system responsible for breaking down fibrin, a component of blood clots. This deficiency leads to the abnormal accumulation of fibrin in the conjunctiva, resulting in the characteristic woody-like pseudomembranes. Genetic mutations in the PLG gene, responsible for producing plasminogen, are often the cause. Environmental factors have not been definitively linked to its onset, underscoring the condition's genetic underpinnings.
- Thick, woody-like membranes forming on the conjunctiva - Reddish to pink eye inflammation - Recurrent eye infections - Impaired vision if the cornea is affected - Bleeding and easy bruising of the affected area - In severe cases, involvement of other mucous membranes leading to respiratory, gastrointestinal, or genitourinary symptoms
Diagnosing ligneous conjunctivitis often involves a combination of clinical examination and laboratory tests. A healthcare professional may initially suspect the condition based on the visible pseudomembranes and the patient's medical history. Confirmatory tests typically include measuring plasminogen activity levels in the blood. Genetic testing for mutations in the PLG gene can also provide a definitive diagnosis. In some cases, a biopsy of the pseudomembrane may be conducted to rule out other conditions with similar manifestations.
Preventing ligneous conjunctivitis focuses on genetic counseling for families with a history of the condition, as current preventive measures are limited due to its genetic nature. Treatment, however, adopts a multifaceted approach. In the realm of functional medicine, enhancing the body's natural healing processes is paramount. Strategies include: - Nutritional supplementation: High-dose oral or topical lysine has been explored due to lysine's role in plasminogen binding, though its effectiveness is anecdotal and requires more research. - Omega-3 fatty acids: Incorporating omega-3 fatty acids through diet or supplements may reduce inflammation associated with the condition. - Antioxidants: Vitamins A, C, and E may help combat oxidative stress in the affected tissues, promoting healing. Traditional treatments involve topical and systemic medications to dissolve fibrin deposits and manage symptoms, including: - Topical plasminogen or fresh frozen plasma: Direct application to the affected areas has shown promise in dissolving pseudomembranes. - Systemic plasminogen therapy: Recently approved in some regions, this treatment addresses the underlying plasminogen deficiency, offering a potential long-term solution. While ligneous conjunctivitis poses significant challenges, the evolving landscape of functional medicine and traditional therapeutic approaches provides hope for effective management and improved quality of life for affected individuals.